|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Genzyme Corporation. 1996. A proposal for regulating predictive genetic testing. Fact Sheet. July. Cambridge, Mass.: Genzyme Corporation. Greely, H.T. 1995. Conflicts in the biotechnology industry. Journal of Law, Medicine and Ethics 23:354-359. Hanna, K.E. 1995. The ethical, legal and social implications program of the National Center for Human Genome Research: a missed opportunity? Pp. 432-454inR.E. Bulger, E.M. Bobby, and H.V. Fineberg, eds., Society's Choices: Social and Ethical Decision Making in Biomedicine. Washington, D.C.: National Academy Press. Hubbard, R., and R.C. Lewontin. 1996. Pitfalls of genetic testing. New England Journal of Medicine 334:1192-1194. Hudson, K.L., K.H. Rothenberg, L.B. Andrews, M.J. Ellis Kahn, and F.S. Collins. 1995. Genetic discrimination and health insurance: An urgent need for reform. Science 270:391-393. Institute of Medicine. 1994. Assessing Genetic Risks: Implications for Health and Social Policy. Washington, D.C.: National Academy Press. Johannes, L. 1995. Detailed map of the genome is now ready. The Wall Street Journal, pp. B 1, B11, Dec. 22. Lerman, C., S. Narod, K. Schulman, C. Hughes, A. Gomez-Caminero, G. Bonney, K. Gold, B. Trock, D. Main, J. Lynch, C. Fulmore, C. Snyder, S. Lemon, T. Conway, P. Tonin, G. Lenoir, and H. Lynch. 1996. BRCA1 testing in families with hereditary breast-ovarian cancer. Journal of the American Medical Association 275:1885-1892. Murphy, P.D. 1996. Testimony for OncorMed Inc. before the Senate Labor and Human Resources Committee hearing on Advances in Genetics Research and Technologies: Challenges For Public Policy. Washington, D.C., July 25. Office of Technology Assessment, U.S. Congress. 1992. Genetic Tests and Health Insurance. Results of a Survey. Publication No. OTA-BP-BA-98. Washington, D.C.: Government Printing Office. Orkin, S.H., and A.G. Motulsky. 1995. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. December 7. Bethesda, Md.: National Institutes of Health. Rothenberg, K.H. 1995. Genetic information and health insurance: State legislative approaches. Journal of Law, Medicine and Ethics 23:312-315. Rothenberg, K.H. 1996. Testimony before the U.S. Senate Committee on Labor and Human Resources hearing on Advances in Genetics Research and Technologies: Challenges for Public Policy , Washington, D.C., July 25. Rothstein, M.A. 1993. Genetics, insurance and the ethics of genetic counseling. Pp. 159-177inMolecular Genetic Medicine, vol. 3. New York: Academic Press. Voelker, R. 1993. The genetic revolution: Despite perfection of elegant techniques, ethical answers still elusive. Journal of the American Medical Association 270:2273-2274.
|
|
|||||||||||||||
